Douglas Pharmaceuticals   Report issue

For profit Phase 1
Founded: Auckland New Zealand (1967)
Status: No NME R&D (1967)

Organization Overview

First Clinical Trial
2020
NCT04203342
First Marketed Drug
2012
isotretinoin (Accutane)
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Douglas Pharmaceuticals America Ltd | DOUGLAS PHARMS

Active Ingredients

Marketed Drugs (1)

isotretinoin (Accutane) (2012)

Drugs in Phase 1 Trials (1)

ketoconazole (nizoral) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tinea (Phase 1)

Tinea Pedis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1